Scientists test Brain-Boosting drug duo to slow early dementia
NCT ID NCT06467539
Summary
This study is testing whether combining two types of drugs works better than one to slow cognitive decline in early Alzheimer's disease or mild cognitive impairment. Researchers will give 80 participants a drug that affects brain signaling (an NMDA-enhancing agent) plus an antioxidant drug for 24 weeks. They will measure changes in memory, thinking skills, daily function, and quality of life to see if the combination is more effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Memorial Hospital
RECRUITINGKaohsiung City, 886, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.